EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative results of use and switching of anti-TNF-alpha agents in adult Behçet’s uveitis

Selma Mesen, Muhammet D Ozer, Muhammed Batur

Indian Journal of Ophthalmology · 2024

DOI: 10.4103/ijo.ijo_2011_23 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Indian Journal of Ophthalmology, 2024. Verfasst von Selma Mesen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Turkoglu Dr. Kemal Beyazit State Hospital Eye Clinic, Türkoğlu, Kahramanmaraş, İstanbul. Hauptthemen laut MEDLINE: Behcet Syndrome, Infliximab, Adalimumab, Visual Acuity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study was planned to compare the clinical results and optical coherence tomography (OCT) data of patients who underwent adalimumab (ADA), infliximab (IFX) and switched protocols between these two methods in cases of Behçet’s associated uveitis (BAU).

Methods

The patients with BAU who were treated with anti-TNF- α agents for at least one year were qualified for the chart review. The outcome parameters were the steroid-free remission state, the best-corrected visual acuity (BCVA), the central macular thickness (CMT), and the subfoveal choroidal thickness (SFCT) of the patients at the last visit.

Results

After a mean follow-up of 16.60 months, the rate of active inflammation decreased from 63.6% to 15.1%. Mean BCVA increased, mean CMT and mean SFCT decreased significantly at the last visit ( P < 0.001, P < 0.001, respectively).

Conclusion

Anti-TNF- α treatment and switching protocols between these two agents effectively and safely control intraocular inflammation in BAU patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromeInfliximabAdalimumabVisual AcuityUveitisTumor Necrosis Factor-alphaDrug SubstitutionHumansMaleAdultTomography, Optical CoherenceFemaleFollow-Up StudiesRetrospective StudiesTreatment OutcomeMiddle AgedYoung AdultChoroid

Substanzen

InfliximabAdalimumabTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Turkoglu Dr. Kemal Beyazit State Hospital Eye Clinic, Türkoğlu, Kahramanmaraş, İstanbul.
  • Gaziosmanpaşa Hospital Ophthalmology Department, Yeni Yüzyıl University, Zeytinburnu, İstanbul.
  • Faculty of Medicine, Ophthalmology Department, Van Yuzuncu Yil University, Tuşba, Van, Türkiye.

Zitieren

APA

Mesen, S., Ozer, M. D., & Batur, M. (2024). Comparative results of use and switching of anti-TNF-alpha agents in adult Behçet’s uveitis. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2011_23

Vancouver

Mesen S, Ozer MD, Batur M. Comparative results of use and switching of anti-TNF-alpha agents in adult Behçet’s uveitis. Indian Journal of Ophthalmology. 2024. doi:10.4103/ijo.ijo_2011_23

BibTeX
@article{Mesen2024,
  author = {Mesen, Selma and Ozer, Muhammet D and Batur, Muhammed},
  title = {Comparative results of use and switching of anti-TNF-alpha agents in adult Behçet’s uveitis},
  journal = {Indian Journal of Ophthalmology},
  year = {2024},
  doi = {10.4103/ijo.ijo_2011_23}
}
Kostenlos starten →